138 related articles for article (PubMed ID: 2545018)
1. Successful treatment of severe cytomegalovirus infections with ganciclovir and CMV hyperimmune globulin in liver transplant recipients.
D'Alessandro AM; Pirsch JD; Stratta RJ; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1989 Jun; 21(3):3560-1. PubMed ID: 2545018
[No Abstract] [Full Text] [Related]
2. Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.
Verdonck LF; de Gast GC; Dekker AW; de Weger RA; Schuurman HJ; Rozenberg-Arska M
Bone Marrow Transplant; 1989 Mar; 4(2):187-9. PubMed ID: 2539877
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
Winston DJ; Busuttil RW
Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients.
Vrtovec B; Thomas CD; Radovancevic R; Frazier OH; Radovancevic B
J Heart Lung Transplant; 2004 Apr; 23(4):461-5. PubMed ID: 15063406
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation.
Stein DS; Verano AS; Levandowski RA
Am J Gastroenterol; 1988 Jun; 83(6):684-6. PubMed ID: 2837082
[TBL] [Abstract][Full Text] [Related]
6. Elimination of cytomegalovirus disease in liver transplant patients treated prophylactically with combination cytomegalovirus hyperimmune globulin and ganciclovir.
Prian GW; Koep LJ
Transplant Proc; 1994 Oct; 26(5 Suppl 1):54-5. PubMed ID: 7940977
[No Abstract] [Full Text] [Related]
7. Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients.
Zamora MR; Fullerton DA; Campbell DN; Leone S; Diercks MJ; Fisher JH; Badesch DB; Grover FL
Transplant Proc; 1994 Oct; 26(5 Suppl 1):49-51. PubMed ID: 7940974
[TBL] [Abstract][Full Text] [Related]
8. DHPG treatment of kidney transplant recipients with severe CMV infection.
Lang P; Buisson C; Rostoker G; Ben Maadi A; Fruchaud G; Deforge L; Chopin D; Abbou C; Romano P; Fleury J
Transplant Proc; 1989 Feb; 21(1 Pt 2):2084-6. PubMed ID: 2540560
[No Abstract] [Full Text] [Related]
9. Prevention of cytomegalovirus disease in heart transplant recipients by prophylaxis with cytomegalovirus hyperimmune globulin plus oral acyclovir.
Eisenmann D; Knipp H; Laube H; Stegmann T
Transplant Proc; 1990 Oct; 22(5):2322-3. PubMed ID: 2171169
[No Abstract] [Full Text] [Related]
10. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
[TBL] [Abstract][Full Text] [Related]
11. Use of ganciclovir plus cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG-Study Group.
George MJ; Snydman DR; Werner BG; Dougherty NN; Griffith J; Rohrer RH; Freeman R; Jenkins R; Lewis WD
Transplant Proc; 1993 Oct; 25(5 Suppl 4):22-4. PubMed ID: 8212303
[No Abstract] [Full Text] [Related]
12. A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group.
Snydman DR; Werner BG; Dougherty NN; Griffith J; Rohrer RH; Freeman R; Jenkins R; Lewis WD; O'Rourke E
Transplant Proc; 1994 Oct; 26(5 Suppl 1):23-7. PubMed ID: 7940972
[No Abstract] [Full Text] [Related]
13. Cytomegalovirus infection in pediatric liver recipients. A virological survey and prophylaxis with CMV immune globulin and early DHPG treatment.
Dussaix E; Wood C
Transplantation; 1989 Aug; 48(2):272-4. PubMed ID: 2547257
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infections in heart and heart-lung transplant recipients.
Wreghitt T
J Antimicrob Chemother; 1989 Jun; 23 Suppl E():49-60. PubMed ID: 2550412
[TBL] [Abstract][Full Text] [Related]
15. Ganciclovir in the treatment of cytomegalovirus pneumonitis in bone marrow transplant recipients.
Milliken S; Powles R; Ettinger N; Gallagher C; Jameson B; Tryhorn Y; Stern H; Selby P
Transplant Proc; 1989 Feb; 21(1 Pt 3):3110-1. PubMed ID: 2539692
[No Abstract] [Full Text] [Related]
16. Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients.
Aulitzky WE; Tilg H; Niederwieser D; Hackl M; Meister B; Huber C
J Infect Dis; 1988 Aug; 158(2):488-9. PubMed ID: 2841384
[No Abstract] [Full Text] [Related]
17. DHPG (Gancyclovir) improves survival in CMV pneumonia.
Mai M; Nery J; Sutker W; Husberg B; Klintmalm G; Gonwa T
Transplant Proc; 1989 Feb; 21(1 Pt 2):2263-5. PubMed ID: 2540565
[No Abstract] [Full Text] [Related]
18. Cytomegalovirus prophylaxis with ganciclovir, acyclovir, and CMV hyperimmune globulin in liver transplant patients receiving OKT3 induction.
Ham JM; Shelden SL; Godkin RR; Posner MP; Fisher RA
Transplant Proc; 1995 Oct; 27(5 Suppl 1):31-3. PubMed ID: 7482814
[No Abstract] [Full Text] [Related]
19. [Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
Gluckman E; McMazeron ; Keable H; Meletis J; Bombail D; Jolivet I; Huart JJ; Nebout T; Cavazzana M; De Castro H
Nouv Rev Fr Hematol (1978); 1987; 29(1):17-21. PubMed ID: 3035485
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic antiviral therapy in CMV high-risk liver transplant recipients.
Rabkin JM; Rosen HR; Corless CL; Orloff SL; Olyaei AJ
Transplant Proc; 2001; 33(1-2):1811-2. PubMed ID: 11267523
[No Abstract] [Full Text] [Related]
[Next] [New Search]
